1. Insight Into the Latest Findings in Migraine

2. Epidemiology of Migraine: Sex Differences From CaMEO Study

3. CaMEO Study: Sex Differences in Consulting Behavior

4. Validation of the MPFID

5. Role of the Hippocampus in Migraine

6. CSD and Prolonged Neuronal Activation and Sensitization

7. CSD and Migraine Headache

8. Brain Trauma and Increased Cortical Network Activity in a Migraine Mutant Mouse

9. Green Light Less Photoallodynic in Migraine Than Blue, Amber, or Red

10. OnabotulinumtoxinA in Prevention of Chronic Migraine: COMPEL Study

11. CGRP

12. Phase 1 Study of Erenumab (AMG334) and Sumatriptan on BP

13. Hepatic Safety of Galcanezumab (LY2951742): Pooled Analysis of Three Phase 2 Studies

14. Efficacy of Erenumab in Episodic Migraine: Phase 3 STRIVE Trial

15. Reduction in Migraine Days and Acute Medication Use With Erenumab: STRIVE

16. Improvement in Activity Scores With Erenumab: STRIVE

17. Efficacy of Erenumab in Episodic Migraine: Phase 3 ARISE Trial Primary Endpoint

18. Reduction in Migraine Days With Erenumab in Chronic Migraine

19. Safety of Erenumab in Episodic Migraine: Phase 3 STRIVE Trial

20. Efficacy of Eptinezumab (ALD403) in Chronic Migraine: Phase 2 Study

21. sTMS in Reduction of Migraine Headache: ESPOUSE Study

22. Zolmitriptan Nasal Spray in Acute Treatment of Adolescents With Migraine

23. Concluding Remarks

24. Abbreviations

25. Abbreviations (cont)

26. Abbreviations (cont)